Title: Professor of Medicine (Emeritus)
Company: Emory University
Location: Atlanta, Georgia, United States
Samuel Newcom, Professor of Medicine (Emeritus) at Emory University, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in medical education.
Dr. Newcom’s mother and father, Grethel and Samuel Newcom, grew up on Iowa farms and physicians were prominent in their hometowns of Denison and Griswold, Iowa. Dr. Newcom’s mother encouraged her son to become a physician. Grethel Newcom’s brother, Dwight Conklin, became a physician (University of Iowa) and practiced general medicine in the U.S. Army, Lake City Iowa, and Oakland, Iowa before specializing in Anesthesiology. Dr. Newcom spent summers in both communities assisting his Uncle and observing the practice of medicine. The Newcom family moved to Berkeley, California in 1958 where his father, Samuel Newcom, could obtain a Master’s in Public Health. After graduating from Berkeley High School, Dr. Newcom enrolled at the University of California, studying at both the Berkeley and Santa Barbara campuses. He received a degree in Psychology and enrolled at the University of Southern California School of Medicine, receiving his M.D. in 1969. He is board certified in internal medicine, hematology and medical oncology (American Board of Internal Medicine).
Following his graduation, Dr. Newcom joined the U.S. Public Health Service (Senior Assistant Surgeon) and was assigned to the Marine Hospital, Staten Island, New York. He returned to the Los Angeles County- University of Southern California Medical Center in 1970 to serve as a Senior Resident in Internal Medicine. He was selected as an N.I.H. Fellow in the Cancer Research Institute at the University of California, San Francisco in 1972 and served an additional year as a Hematology Fellow. In 1974 he entered private practice at the Portland Clinic for one year and served as an Instructor in Medicine at the Oregon Health Sciences University. He then returned to San Francisco as an assistant professor and chief of the medical oncology clinic at the University of California from 1975 to 1979. The Oregon Health Sciences University asked him to return to Portland as an Associate Professor of Medicine and founding Director of Medical Oncology. It was necessary for Dr. Newcom to sue the State of Oregon to block the activities of the Hemlock Society within the University and fully establish a Medical Oncology Program (United States Civil No. 81-1015-RE). This lawsuit (Judge James Redden presiding) promoted the Oregon Law prohibiting physicians from directly administering lethal medications to cancer patients (Oregon Suicide Law) and promoted the development of the Oregon Health and Sciences University Cancer Hospital (currently the Knight Cancer Center). In 1984. Dr. Newcom resigned his Associate Professorship in Oregon and accepted a tenured Professorship at Emory University where he now holds emeritus status.
Dr. Newcom has achieved a great deal throughout the course of his career. He characterized the Reed-Sternberg cell in Hodgkin’s disease as a malignant lymphocyte, demonstrated the attempt by T-lymphocytes to kill this cell, and identified the proteins inhibiting these T-cells (Newcom, SR, et al, Pub Med). He demonstrated the ability to cure Hodgkin’s in HIV patients and suggested clinical evidence of a transmissible agent responsible for this malignancy. He organized political protests in Atlanta, Georgia, to obtain public funding for Grady Memorial Hospital, achieved Georgia U.S. Congressional support for passage of the Affordable Care Act, and implantation of the ACA in Georgia. Dr. Newcom considers achieving funding for continuing his research to be a career highlight and is proud of his research and securing funding.
In addition to these pursuits, Dr. Newcom was the chief of the lymphoma leukemia service at the Grady Memorial Hospital as well as chief of hematology and oncology service at Atlanta Veteran’s Affairs Hospital. He has presented his research to local, national and international science organizations, served as an editor for Supplemental 5 Blood, Hematologic Malignancies in the Adult, an assistant editor for the American Journal of Medical Science, and has contributed articles to professional journals.
Contact Dr. Newcom: